Dr. Medsger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 5th Ave
Falk Medical Building
Pittsburgh, PA 15213Phone+1 412-647-6700
Education & Training
- University of TennesseeFellowship, Rheumatology, 1968 - 1969
- UPMC Medical EducationResidency, Internal Medicine, 1965 - 1968
- University of Miami/Jackson Health SystemInternship, Transitional Year, 1962 - 1963
- Perelman School of Medicine at the University of PennsylvaniaClass of 1962
Certifications & Licensure
- PA State Medical License 1966 - 2018
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Top MD Consumers Checkbook
Clinical Trials
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
Publications & Presentations
PubMed
- 1771 citations2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiativeFrank H J van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron
Arthritis and Rheumatism. 2013-11-01 - 1569 citations2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeFrank H J van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron
Annals of the Rheumatic Diseases. 2013-11-01 - 1096 citationsChanges in causes of death in systemic sclerosis, 1972-2002.Virginia D. Steen, Thomas A. Medsger
Annals of the Rheumatic Diseases. 2007-07-01
Journal Articles
- Anti‐RNPC3 (U11/U12) Antibodies in Systemic Sclerosis Are Associated with Moderate to Severe Gastrointestinal DysmotilityRobyn T Domsic, Ami A Shah, Thomas A Medsger, Zsuzsanna H McMahan, Arthritis Care & Research
Press Mentions
- My First Question Is — What Is Your Antibody Type? I Can Better Comment on the Issue of “Spontaneous Remission” Once I Know ThatJanuary 9th, 2017
- Dr. Wolfe & the National Data Bank for Rheumatic Diseases (NBD)September 19th, 2023
Grant Support
- Relaxin In Systemic Sclerosis W/ Diffuse SclerodermaNational Center For Research Resources2000–2002
- Double Blind Study With Oral Iloprost And Placebo In Raynaud'S PhenomenonNational Center For Research Resources1997
- Multicenter Evaluation Of Pilocarpine HCL In Sjogrens SyndromeNational Center For Research Resources1996–1997
Professional Memberships
- Master Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: